Abstract: Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
Type:
Grant
Filed:
May 30, 2003
Date of Patent:
April 19, 2005
Assignee:
Novo Nordick A/S
Inventors:
Jesper Lau, Inge Thoger Christensen, Peter Madsen, Paw Bloch, Carsten Behrens, Janos Tibor Kodra, Poul Enrico Nielsen